Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation.
Montano-Loza AJ, Lytvyak E, Hirschfield G, Hansen BE, Ebadi M, Berney T, Toso C, Magini G, Villamil A, Nevens F, Van den Ende N, Pares A, Ruiz P, Terrabuio D, Trivedi PJ, Abbas N, Donato MF, Yu L, Landis C, Dumortier J, Dyson JK, van der Meer AJ, de Veer R, Pedersen M, Mayo M, Manns MP, Taubert R, Kirchner T, Belli LS, Mazzarelli C, Stirnimann G, Floreani A, Cazzagon N, Russo FP, Burra P, Zigmound U, Houri I, Carbone M, Mulinacci G, Fagiuoli S, Pratt DS, Bonder A, Schiano TD, Haydel B, Lohse A, Schramm C, Rüther D, Casu S, Verhelst X, Beretta-Piccoli BT, Robles M, Mason AL, Corpechot C; Global PBC Study Group.
J Hepatol. 2024 Oct;81(4):679-689. doi: 10.1016/j.jhep.2024.05.010. Epub 2024 May 29.
PMID:38821360
The 2024 diagnostic criteria for primary sclerosing cholangitis.
Naitoh I, Isayama H, Akamatsu N, Mizuno S, Fujisawa T, Nakamoto N, Nakai Y, Umetsu S, Suzuki M, Yagi S, Haga H, Notohara K, Sano K, Tazuma S, Nakazawa T, Tanaka A.
J Gastroenterol. 2025 Oct;60(10):1221-1231. doi: 10.1007/s00535-025-02265-5. Epub 2025 Jun 12.
PMID:40504416
Recurrent primary sclerosing cholangitis: Clinical diagnosis and long-term management issues.
Recurrent ascending cholangitis with acute pancreatitis and pancreatic atrophy caused by a juxtapapillary duodenal diverticulum: A case report and literature review.
Alzerwi NAN.
Medicine (Baltimore). 2020 Jul 2;99(27):e21111. doi: 10.1097/MD.0000000000021111.